RecruitingPhase 3NCT07120763

Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures

Sponsor

State University of New York at Buffalo

Enrollment

50 participants

Start Date

Aug 22, 2025

Study Type

INTERVENTIONAL

Conditions

Pain Control Distal Radius Fracture Reduction Pediatric Fractures

Summary

The aim of this study is to evaluate the efficacy of a hematoma block and minimal ketamine pain control or hematoma block and intranasal fentanyl in pediatric patients presenting with distal radius fractures requiring reduction, compared to control of standard full conscious sedation using ketamine.

Eligibility

Min Age: 3 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Fentanyl (Nasalfent, Fentanyl Citrate Nasal Spray), a drug called Ketamine + Lidocaine, and others for people with distal radius fracture reduction, pain control, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 3 Years to 17 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetamine + Lidocaine

Including comparisons between patients randomized for treatment with full ketamine sedation in setting of distal radius fracture reduction, hematoma block/minimal ketamine pain control (. 0.25mg/kg) for distal radius fracture reduction, or intranasal fentanyl and hematoma block, utilized in the setting of distal radius fractures in pediatric patients requiring reduction

DRUGKetamine group

DRUGFentanyl (Nasalfent, Fentanyl Citrate Nasal Spray)